Ranking International Biotechnology
I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing […]
General Biotechnology, Talks and Publications
Featured, Guest content
Spread your message with BiotechBlog
Post your content on BiotechBlog and have it syndicated across the web. Send me a pitch using the contact form. Guidelines
General Biotechnology
Join the Journal of Commercial Biotechnology Discussion Group
Join the Journal of Commercial Biotechnology discussion group on LinkedIn: http://www.linkedin.com/groups?gid=1241807 This group focuses on the biotech industry. The audience
Join the Journal of Commercial Biotechnology Discussion Group Read Post »
General Biotechnology
Slow Posting — New Project in the Works
Those who have been following this blog for long enough probably know what it means when posting slows down —
General Biotechnology, Talks and Publications
Journal of Commercial Biotechnology — October 2008
The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to
Journal of Commercial Biotechnology — October 2008 Read Post »
General Biotechnology, Guest content
Intellectual Property Theft on the Rise
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John
General Biotechnology, Talks and Publications
Biotechnology Career Development
Two upcoming talks on biotechnology career development strategies at Johns Hopkins campuses: Homewood Campus Friday, Oct. 17th 2008 5:30-7:30pm Remsen
General Biotechnology, Talks and Publications
Seeking experienced industry insiders for book series
I’d like to build on the success of my “Best Practices in Biotechnology…” book series by producing more edited compilations
Seeking experienced industry insiders for book series Read Post »
General Biotechnology
When will the U.S. develop concise generic biologic rules?
A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in
When will the U.S. develop concise generic biologic rules? Read Post »
General Biotechnology, Guest content
Commercializing biotechnology in China
I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience
